PharmaDeals: PharmaDeals Review: Table of Contents

<< Previous Issue

Aug-Sep 03 2003 (Vol:2003, Issue: 39)

Next Issue >>

Download pdf of entire issue

Section: Company Profile
Epigenomics AG Published: 1 Aug-2003
By: Business Review Editor
Abstract Fulltext:
GPC Biotech AG Published: 1 Aug-2003
By: Business Review Editor
Abstract Fulltext:
Section: Distribution & Marketing
SkyePharma License Marketing and Distribution Rights for DepoCyte® to Mundipharma Published: 1 Aug-2003
By: Business Review Editor
Abstract Fulltext:
Section: General
Millennium, J&J and Velcade Published: 1 Aug-2003
By: Business Review Editor
Abstract
Quid Pro Quo Deals Published: 1 Aug-2003
By: Business Review Editor
Abstract
Therapy Focus: Migraine Published: 1 Aug-2003
By: Business Review Editor
Abstract
Section: Licensing
Boehringer Licenses Medivir’s MIV-310 Antiviral Drug Published: 1 Aug-2003
By: Business Review Editor
Abstract Fulltext:
Pozen and Nycomed Enter into Option Agreement for NSAID Lornoxicam Published: 1 Aug-2003
By: Business Review Editor
Abstract Fulltext:
Section: Mergers & Acquisitions
Roche Acquires Cardion’s IL-15 Antagonist Published: 1 Aug-2003
By: Business Review Editor
Abstract Fulltext:
Genzyme Expands Immunology Portfolio Through Sangstat Acquisition Published: 1 Aug-2003
By: Business Review Editor
Abstract Fulltext:
Section: Research & Development
Aventis and ImmunoGen Enter Anticancer Antibody Collaboration Published: 1 Aug-2003
By: Business Review Editor
Abstract Fulltext:

Bookmark PharmaDeals through one of these social networks.

Table of Contents